First tranche delivered, larger tranches en route: the same engine that just produced has visibly more already scheduled
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO. Need analyze transcript for identifiable engine of new business with first tranche landed and larger tranches in motion, same engine, remainder larger, management affirms. Need use only transcript. We need find candidate. Let's parse. Management discusses many products. Need one where first concrete delivery in Q3 and more already committed/scheduled/ramping, remainder larger. Examples: Dupixent launches, Pentaxim China recovery, Flublok, Cablivi, Libtayo, Admelog, etc. Need identify if management describes first tranche landed and larger tranches in motion. For example, Pentaxim in China: supply recovery, sales in Q3. They say "recovery of Pentaxim supply in China" contributed. They say "we were able to release the Pentaxim earlier than estimated... Chinese authorities accelerating release... high demand because of vaccine scandal... outlook improved." But is there a larger tranche already in motion? They mention catch-up doses and demand. But not necessarily committed volumes. Maybe not. Dupixent: launched in multiple countries, approvals. First tranche? Sales growing. But continuation? More indications, asthma launch just approved. But is that same engine? Maybe not. Cablivi: European approval, launch underway in Germany, U.S. approval expected Feb 2019. First tranche landed? Launch in Germany, sales? They don't give sales. They describe launch underway, price. But larger tranches? U.S. approval not yet obtained, so no. Libtayo: FDA approval, launch underway with Regeneron, European approval expected H1 2019. First tranche landed? Launch underway, but no sales. Larger tranche? Europe not approved yet, so no. Admelog: Q3 sales €26 million, access in Managed Medicaid. Future? They say "will likely not be contracted in Medicare in 2019... rather in 2020." So continuation not secured. Praluent: sales up 64%, exclusive coverage by Express Scripts. For 2019, payer coverage lower, quality improved. But not larger tranches committed? Maybe not. Need find one where management explicitly says first portion delivered and more already in motion, remainder larger. Could be "new product launches now delivering revenues greater than LoE impact" but that's aggregate. Maybe "Bioverativ" acquisition? Not. Let's examine transcript for phrases like "first", "initial", "launch", "ramp", "committed", "scheduled", "in motion".
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| ATAT | Atour Lifestyle Holdings Limited | Q1 2024 | 2024-05-23 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| ZLAB | Zai Lab Limited | Q4 2023 | 2024-02-28 | C |
| VMI | Valmont Industries, Inc. | Q4 2023 | 2024-02-22 | C |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| CLNE | Clean Energy Fuels Corp. | Q2 2023 | 2023-08-09 | C+ |
| LUCD | Lucid Diagnostics Inc. | Q1 2023 | 2023-05-16 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| ARE | Alexandria Real Estate Equities, Inc. | Q4 2022 | 2023-01-31 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| FEIM | Frequency Electronics, Inc. | Q1 2019 | 2018-09-13 | B+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MGA | Magna International Inc. | Q1 2018 | 2018-05-10 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| HR | Healthcare Realty Trust Incorporated | Q1 2017 | 2017-05-08 | A |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| MTRX | Matrix Service Company | Q3 2016 | 2016-05-05 | D |
| CLF | Cleveland-Cliffs Inc. | Q1 2016 | 2016-04-29 | F |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
CDMO · Q3 2022 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: NO The transcript describes the first phase of the Myford expansion as now operational and scheduling client projects, with management noting they are already utilizing the new space and that an extra $5 million is arguably in backlog attributable to it.
LINC · Q1 2024 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: YES The transcript identifies the new-campus expansion strategy as the engine. East Point opened in Q1 with 29 starts and $90k revenue (first tranche, concrete and delivered).
LTRX · Q3 2024 → YESThe question is about whether management describes one identifiable engine of new business that meets two criteria: a first tranche has actually landed in the just-reported period, and larger tranches...